Merck & Co said on Wednesday it will supply about 60,000-100,000 doses of its COVID-19 treatment to the U.S. government for up to about US$356 million.
Recent Posts
Most Popular
Bank of Japan expects rising inflation to spur demand for new financial services
JAPAN needs to promote digitalisation as rising inflation and interest rates will increase demand for new financial services from households, a Bank...